---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-021262"
form_type: "8-K"
ticker: "PRPH"
cik: "0000868278"
company_name: "ProPhase Labs, Inc."
filed_at: "2025-07-29T23:59:59+00:00"
generated_at: "2026-05-17T23:55:12.589191+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# ProPhase Labs to seek shareholder approval to increase authorized shares to 1 billion for crypto treasury strategy

## Summary
- Special Meeting of Shareholders on August 29, 2025 to vote on increasing authorized shares to 1 billion.
- Board unanimously recommends approval to attract high-value crypto treasury transactions and market participants.
- Company aims to collect approximately $50 million from COVID accounts receivables to fund potential crypto strategy.
- Continuing development of BE-Smart esophageal cancer test and exploring strategic alternatives for Nebula Genomics, including a possible sale.

## SEC filing metadata
- accession: 0001641172-25-021262
- form_type: 8-K
- ticker: PRPH
- cik: 0000868278
- company_name: ProPhase Labs, Inc.
- filed_at: 2025-07-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/868278/000164117225021262/0001641172-25-021262-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/868278/000164117225021262/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-021262
- JSON: https://secwatch.observer/filing/0001641172-25-021262.json
- Plain text: https://secwatch.observer/filing/0001641172-25-021262.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.